The Growing Relevance of Immunoregulation in Pediatric Brain Tumors
Pediatric brain tumors are genetically heterogeneous solid neoplasms. With a prevailing poor prognosis and widespread resistance to conventional multimodal therapy, these aggressive tumors are the leading cause of childhood cancer-related deaths worldwide. Advancement in molecular research revealed...
Guardado en:
Autores principales: | Viktoria Melcher, Kornelius Kerl |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/68e940d503584f9384e8c10427a4eeca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
por: Pauline Thomas, et al.
Publicado: (2021) -
SEIZURES IN CHILDREN WITH LOW GRADE GLIOMA
por: Piyush Ostwal, et al.
Publicado: (2021) -
An atypical teratoid/rhabdoid tumor (AT/RT) with molecular features of pleomorphic xanthoastrocytoma (PXA) in a 62-year-old patient
por: Matthias Dottermusch, et al.
Publicado: (2021) -
Pediatric and Adult Low-Grade Gliomas: Where Do the Differences Lie?
por: Ladina Greuter, et al.
Publicado: (2021) -
From Focused Ultrasound Tumor Ablation to Brain Blood Barrier Opening for High Grade Glioma: A Systematic Review
por: Luca Paun, et al.
Publicado: (2021)